Skip to content

Clinical trials

Phase 1/2 Small Cell Lung Carcinoma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Status: Unknown status Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20141
20151
20171
20191
20202
20212
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Advenchen Laboratories Nanjing Ltd.1
Affiliated Hospital to Academy of Military Medical Sciences1
Andarix Pharmaceuticals1
Biocity Biopharmaceutics Co., Ltd.1
Chipscreen Biosciences, Ltd.1
Fujian Cancer Hospital1
Fundacion Oncosur1
Gachon University Gil Medical Center1
JenKem Technology Co., Ltd.1
Sun Yat-sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma14
Anus Neoplasms1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Small Cell1
Carcinoma, Squamous Cell1
Lung Neoplasms1
Neoplasm Recurrence, Local1
Neoplasms1
Stomach Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.